Psychosocial Support for Pediatric Patients at Proton Therapy Institutions [0.03%]
质子治疗机构中的儿科患者心理社会支持
Nicole Boik,Matthew D Hall
Nicole Boik
Purpose: Pediatric patients with cancer benefit significantly from psychosocial support during and after treatment, but to date, limited data exist regarding the patterns of psychosocial support provided to patients in ra...
Longitudinal Quantitative Analysis of Radiation Oncology Staff Illness in a New York City Center during COVID-19: The Impact of New Guidelines on Operations and Employee Health [0.03%]
COVID-19大流行期间纽约市一家癌症放射治疗中心工作人员疾病的纵向定量分析：新指南对运营和员工健康的影响
Shaakir Hasan,Robert H Press,Arpit Chhabra et al.
Shaakir Hasan et al.
Purpose: The novel coronavirus (COVID-19) forced radiation oncology clinics to overhaul operational policies, but the effect on employee safety has not, to our knowledge, been reported. The New York Proton Center (NYPC), ...
Proton Therapy as a Bridging Treatment in CAR T-Cell Therapy for Relapsed and Refractory Large B-Cell Lymphoma: Is There a Role? [0.03%]
质子治疗在复发和难治性大B细胞淋巴瘤的CAR T细胞治疗中的桥梁治疗作用：是否有用？
Omran Saifi,Mohamed A Kharfan-Dabaja,Youssef H Zeidan et al.
Omran Saifi et al.
Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma. Since the relapse rate of DLBCL to frontline chemoimmunotherapy and salvage autologous hematopoietic cell transplant is high, CD19-directed chimeric anti...
Reducing Heart Dose with Protons and Cardiac Substructure Sparing for Mediastinal Lymphoma Treatment [0.03%]
使用质子束降低心脏剂量及对纵隔淋巴瘤治疗中心脏亚结构的保护
Kekoa Taparra,Scott C Lester,W Scott Harmsen et al.
Kekoa Taparra et al.
Purpose: Electrocardiogram-gated computed tomography with coronary angiography can be used for cardiac substructure sparing (CSS) optimization, which identifies and improves avoidance of cardiac substructures when treatin...
Prioritization of Proton Patients in the COVID-19 Pandemic: Recommendations from The New York Proton Center [0.03%]
新冠病毒大流行下的质子患者优先治疗推荐——纽约质子中心的观点
Arpit M Chhabra,J Isabelle Choi,Shaakir Hasan et al.
Arpit M Chhabra et al.
It has been well documented from the early days of the 2019 novel coronavirus (COVID-19) pandemic that patients with a diagnosis of cancer are not only at higher risks of contracting a COVID-19 infection but also at higher risks of sufferin...
Monte Carlo Simulations of Neutron Ambient Dose Equivalent in a Novel Proton Therapy Facility Design [0.03%]
新设计质子治疗设施中快中子环境剂量当量的蒙特卡罗模拟研究
Uwe Titt,Enzo Pera,Michael T Gillin
Uwe Titt
Purpose: The neutron shielding properties of the concrete structures of a proposed proton therapy facility were evaluated with help of the Monte Carlo technique. The planned facility's design omits the typical maze-struct...
Temporal Lobe Necrosis in Head and Neck Cancer Patients after Proton Therapy to the Skull Base [0.03%]
头颈部肿瘤患者经质子治疗后出现颞叶坏死病症的病例分析
Sarin Kitpanit,Anna Lee,Ken L Pitter et al.
Sarin Kitpanit et al.
Purpose: To demonstrate temporal lobe necrosis (TLN) rate and clinical/dose-volume factors associated with TLN in radiation-naïve patients with head and neck cancer treated with proton therapy where the field of radiatio...
Irradiating Residual Disease to 30 Gy with Proton Therapy in Pediatric Mediastinal Hodgkin Lymphoma [0.03%]
儿童纵隔霍奇金淋巴瘤患者接受质子治疗残留病灶的剂量为30Gy
Bradford S Hoppe,Raymond B Mailhot Vega,Nancy P Mendenhall et al.
Bradford S Hoppe et al.
Background: Local relapse is a predominant form of recurrence among pediatric patients with Hodgkin lymphoma (PHL). Although PHL radiotherapy doses have been approximately 20 Gy, adults with Hodgkin lymphoma receiving 30 ...
Predicted Secondary Malignancies following Proton versus Photon Radiation for Oropharyngeal Cancers [0.03%]
预测头颈部肿瘤质子治疗和光子治疗后继发恶性肿瘤发生的风险
Varsha Jain,Peyton Irmen,Shannon O&#x;Reilly et al.
Varsha Jain et al.
Purpose: There has been a recent epidemic of human papillomavirus (HPV)-positive oropharyngeal cancer, accounting for 70% to 80% of diagnosed cases. These patients have an overall favorable prognosis and are typically tre...
Proceedings to the 6th Annual Conference of the Particle Therapy Cooperative Group North America (PTCOG-NA): 14-16 October 2019, Hosted by Miami Cancer Institute, part of Baptist Health South Florida, Miami, FL, USA [0.03%]
粒子治疗合作组织北美分会(PTCOG-NA)第六届年度大会报告：2019年10月14日至16日，佛罗里达州迈阿密市 Baptist Health南佛罗里达州迈阿密癌症研究所主办